Anette Sams has worked as a pharmaceutical researcherincluding six years at Novo Nordisk, where she specialized in and led research on blood sugar, diabetes, and inflammationand shes now sharing her expertise worldwide
161,168 The most significant pharmacokinetic alterations were reported following the administration of a single 5 mg dose of tirzepatide, with the C max and AUC values of ethinylestradiol decreasing by 59% and 21%, respectively, and those of norelgestromin by 55% and 22%, respectively (Table 4)
There are no reports of adverse effects on the breastfed infant
Until then, the risks will keep stacking up
After adjusting for insulin resistance, the differences in GLP-1 sensitivity between lean and obese subjects were no longer significant, suggesting that its effects are modulated by the individuals insulin sensitivity status